# Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer

> **NCT00004087** · PHASE1,PHASE2 · COMPLETED · sponsor: **Garden State Cancer Center at the Center for Molecular Medicine and Immunology** · enrollment: 15 (estimated)

## Conditions studied

- Colorectal Cancer
- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** indium In 111 monoclonal antibody MN-14
- **RADIATION:** yttrium Y 90 monoclonal antibody MN-14

## Key facts

- **NCT ID:** NCT00004087
- **Lead sponsor:** Garden State Cancer Center at the Center for Molecular Medicine and Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-03
- **Primary completion:** 2001-05
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2011-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004087, "Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00004087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*